← Leaderboards
Zhao Wang
Ut Southwestern Medical Center
$7,768,143
Attributed
$7,768,143
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,768,143 · 3
By mechanism
R01$7,768,143 · 3
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Philipp E Scherer$40,932,820
Others in their field
Other Emerging Leaders on “Experimental Study”
- John Hobbs · Suny At Stony Brook$42,194,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Christopher Bee · Suny At Stony Brook$41,239,084
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,024,342
- John Damon Chodera · Sloan-Kettering Inst Can Research$18,835,102
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
Research focus
Experimental StudyNovel Therapeutic InterventionRisk FactorsStressLoss Of FunctionResponseInsightMouse ModelPressureSignal PathwayHeartIn VivoGrowthMolecularAcuteHeart FailureHypertensionHeart HypertrophyCardiacCardiac MyocytesPathologicMetabolicEnzymesAnabolism
Grant awards (16)
Integrative role of Rps6kb1 in pathological cardiac remodeling$846,536
R01 · FY2025 · HL · contact PI
Role of the unfolded protein response in pathological cardiac remodeling$575,395
R01 · FY2025 · HL · contact PI
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling$440,000
R01 · FY2025 · HL · contact PI
Integrative role of Rps6kb1 in pathological cardiac remodeling$846,536
R01 · FY2024 · HL · contact PI
Role of the unfolded protein response in pathological cardiac remodeling$563,886
R01 · FY2024 · HL · contact PI
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling$440,000
R01 · FY2024 · HL · contact PI
Role of the unfolded protein response in pathological cardiac remodeling$575,395
R01 · FY2023 · HL · contact PI
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling$440,000
R01 · FY2023 · HL · contact PI
Role of the unfolded protein response in pathological cardiac remodeling$575,395
R01 · FY2022 · HL · contact PI
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling$440,000
R01 · FY2022 · HL · contact PI
Role of the Xbp1s/GFAT1 axis in pathological cardiac remodelling$301,796
R01 · FY2021 · HL · contact PI
Role of the Xbp1s/GFAT1 axis in pathological cardiac remodelling$103,204
R01 · FY2021 · HL · contact PI
Role of the Xbp1s/GFAT1 axis in pathological cardiac remodelling$405,000
R01 · FY2020 · HL · contact PI
Role of the Xbp1s/GFAT1 axis in pathological cardiac remodelling$405,000
R01 · FY2019 · HL · contact PI
Role of the Xbp1s/GFAT1 axis in pathological cardiac remodelling$405,000
R01 · FY2018 · HL · contact PI
Role of the Xbp1s/GFAT1 axis in pathological cardiac remodelling$405,000
R01 · FY2017 · HL · contact PI